National Pharmaceutical Pricing Authority

(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 5^th June, 2008)

Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)

New Delhi, the 5^th June, 2008

ORDER

S.O.1337(E) – In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Pfizer Products India Pvt. Ltd.

TABLE

Sl. No.	Name of the Formulation	Pack Size	Existing Retail Price (Rs.)	Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.)	*Equivalent MRP(inclusive of all taxes)(Rs.)**
(1)	(2)	(3)	(4)	(5)	(6)
1	Depomedrol 40mg Each ml contains Methyl Prednisolone Acetate – 40mg Batch No. R00204 Qty. 116524	1ml vial	48.67	49.65	51.64
2	Depomedrol 80mg Each ml contains Methyl Prednisolone Acetate – 80mg Batch No. R01131 Qty. 157012 Batch No. R00210 Qty. 100503	2ml vial	71.89	72.98	75.90
3	Solu Medrol 125mg AOV Each Vial contains Methyl Prednisolone Sodium Succinate – 125mg Batch No. R00062 Qty. 47583	2ml vial	227.75	231.75	241.02
4	Solu Medrol AOV 500mg Each Vial contains Methyl Prednisolone Sodium Succinate – 500mg Batch No. OAKKO Qty. 23197 Batch No. OAMF6 Qty. 23236	4ml vial	555.54	560.52	582.94
5	Solu Medrol AOV 1000mg Each Vial contains Methyl Prednisolone Sodium Succinate – 1000mg Batch No. OAMXJ Qty. 34780	8ml vial	895.51	910.55	946.97
6	Medrol 4mg tablets Each tablet contains Methyl Prednisolone – 4mg Batch No. G902C Qty. 11308 Batch No. G604A Qty. 32568 Batch No. G904A & G905A Qty. 17680 Batch No. G904A & G902C Qty. 34526 Batch No. G603B Qty. 11048	10×10’s Tablet	289.95	294.71	306.50
7	Medrol 16mg tablets Each tablet contains Methyl Prednisolone – 16mg Batch No. G933A Qty. 48096	14’s Tablet	127.62	129.64	134.83

*Subject to actual payment of Government levies/taxes, as applicable.

NOTE :

(a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

PN/101/2008/F

F.No. 8(11)/2008/D.P./NPPA-Div.II

(RAJIV WADHAWAN)
Deputy Director
National Pharmaceutical Pricing Authority

Last Page Updated: 03-06-2019

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)